Udo Oppermann

21.0k total citations · 2 hit papers
241 papers, 13.8k citations indexed

About

Udo Oppermann is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cell Biology. According to data from OpenAlex, Udo Oppermann has authored 241 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Molecular Biology, 43 papers in Endocrinology, Diabetes and Metabolism and 42 papers in Cell Biology. Recurrent topics in Udo Oppermann's work include Epigenetics and DNA Methylation (42 papers), Hormonal Regulation and Hypertension (34 papers) and Aldose Reductase and Taurine (32 papers). Udo Oppermann is often cited by papers focused on Epigenetics and DNA Methylation (42 papers), Hormonal Regulation and Hypertension (34 papers) and Aldose Reductase and Taurine (32 papers). Udo Oppermann collaborates with scholars based in United Kingdom, Sweden and United States. Udo Oppermann's co-authors include K.L. Kavanagh, Bengt Persson, Hans Jörnvall, Yvonne Kallberg, Hans Jörnvall, Charlotta Filling, Xiaoqiu Wu, James E. Dunford, Christopher J. Schofield and Wyatt W. Yue and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Udo Oppermann

239 papers receiving 13.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Medium- and short-chain dehydrogenase/reductase gene and protein families

2008 699 citations K.L. Kavanagh, Bengt Persson et al. profile →
Short-chain dehydrogenases/reductases (SDR): the 2002 update

2003 552 citations Udo Oppermann, N. Shafqat et al. profile →

Peers

Countries citing papers authored by Udo Oppermann

Since Specialization

Citations

This map shows the geographic impact of Udo Oppermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udo Oppermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udo Oppermann more than expected).

Fields of papers citing papers by Udo Oppermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Udo Oppermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udo Oppermann. The network helps show where Udo Oppermann may publish in the future.

Co-authorship network of co-authors of Udo Oppermann

This figure shows the co-authorship network connecting the top 25 collaborators of Udo Oppermann. A scholar is included among the top collaborators of Udo Oppermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Udo Oppermann. Udo Oppermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma 2024 ·Cell Reports Medicine ·Oliver Van Oekelen, Michael Amatangelo, Manman Guo, Bhaskar Upadhyaya, Adam P. Cribbs, Geoff Kelly, Manishkumar Patel, Seunghee Kim‐Schulze, Erin Flynt, Alessandro Laganà, Sarah Gooding, Miriam Mérad, (unknown), William E. Pierceall, Udo Oppermann, Anjan Thakurta, Samir Parekh	7
2	HSD3B1 is an oxysterol 3β-hydroxysteroid dehydrogenase in human placenta 2023 ·Open Biology ·(unknown), Eylan Yutuc, Catherine A. Thornton, James E. Dunford, Udo Oppermann, Yuqin Wang, William J. Griffiths	4
3	Discovery of a Potent and Selective Naphthyridine-Based Chemical Probe for Casein Kinase 2 2023 ·ACS Medicinal Chemistry Letters ·Zachary W. Davis‐Gilbert, Andreas Krämer, James E. Dunford, (unknown), (unknown), Carrow I. Wells, (unknown), Tammy M. Havener, Jeffery L. Smith, Mohammad Anwar Hossain, Udo Oppermann, David H. Drewry, Alison D. Axtman	11
4	Immune response to COVID ‐19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T‐cell response 2022 ·British Journal of Haematology ·Karthik Ramasamy, Ross Sadler, (unknown), (unknown), (unknown), Alison Turner, (unknown), Nathanael S. Gray, (unknown), (unknown), Stella Bowcock, Udo Oppermann, Gordon Cook, Chara Kyriakou, Mark T. Drayson, Supratik Basu, Sally Moore, Sarah McDonald, Sarah Gooding, M K Javaid	14
5	Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance 2022 ·Nature Communications ·(unknown), N. Connor Payne, C. Johansson, (unknown), Sofia A. Santos, Lọla Fagbami, (unknown), Kayla Sylvester, Madeline R. Luth, Sofia Marques, Malcolm Whitman, Maria M. Mota, Elizabeth A. Winzeler, Amanda K. Lukens, Emily R. Derbyshire, Udo Oppermann, Dyann F. Wirth, Ralph Mazitschek	16
6	Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death 2020 ·Cancer Research ·Lucia Cottone, Adam P. Cribbs, Garima Khandelwal, Graham Wells, (unknown), Martin Philpott, Anthony Tumber, Patrick Lombard, Edward S. Hookway, Tamás Szommer, C. Johansson, Paul E. Brennan, Nischalan Pillay, Richard G. Jenner, Udo Oppermann, Adrienne M. Flanagan	35
7	Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism 2020 ·Proceedings of the National Academy of Sciences ·Adam P. Cribbs, (unknown), Martin Philpott, Jeroen Baardman, David Ahern, Morten Lindow, Susanna Obad, Henrik Oerum, Brante P. Sampey, Palwinder K. Mander, Henry Penn, B P Wordsworth, Paul Bowness, Menno P.J. de Winther, Rab K. Prinjha, Marc Feldmann, Udo Oppermann	73
8	Role of protein structure in variant annotation: structural insight of mutations causing 6-pyruvoyl-tetrahydropterin synthase deficiency 2019 ·Pathology ·J.R.C. Muniz, (unknown), Rebecca Frise, Wen‐Hwa Lee, (unknown), Beat Thöny, Nastassja Himmelreich, Nenad Blau, Kwang-Jen Hsiao, Tze-Tze Liu, O. Gileadi, Udo Oppermann, F. von Delft, Wyatt W. Yue, Nelson L.S. Tang	7
9	Multidimensional Single Cell Analysis Shows Increased T/NK Cell Subsets in Both Blood and Bone Marrow of Iberdomide (CC-220) Treated Relapsed/Refractory Multiple Myeloma Patients 2019 ·Blood ·Michael Amatangelo, Oliver Van Oekelen, Adeeb Rahman, Alessandro Laganà, Sarah Gooding, Hervé Avet‐Loiseau, Udo Oppermann, William E. Pierceall, Anjan Thakurta, Samir Parekh	9
10	Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity 2018 ·Journal of Medicinal Chemistry ·Shyh‐Ming Yang, Natalia J. Martinez, Adam Yasgar, Carina Danchik, C. Johansson, Yuhong Wang, Bolormaa Baljinnyam, Amy Q. Wang, Xin Xu, Pranav Shah, Dorian M. Cheff, (unknown), Jacob S. Roth, Madhu Lal‐Nag, James E. Dunford, Udo Oppermann, Vasilis Vasiliou, Anton Simeonov, Ajit Jadhav, David J. Maloney	70
11	Investigatingd-lysine stereochemistry for epigenetic methylation, demethylation and recognition 2017 ·Chemical Communications ·(unknown), (unknown), Kiran Kumar, Bas J. G. E. Pieters, Anthony Tumber, James E. Dunford, C. Johansson, Udo Oppermann, Tom Brown, Christopher J. Schofield, Richard J. Hopkinson, Robert S. Paton, Akane Kawamura, Jasmin Mecinović	26
12	Crystal structure of PHYHD1A, a 2OG oxygenase related to phytanoyl-CoA hydroxylase 2011 ·Biochemical and Biophysical Research Communications ·Zhihong Zhang, Grazyna Kochan, Stanley S. Ng, K.L. Kavanagh, Udo Oppermann, Christopher J. Schofield, M.A. McDonough	20
13	A miniaturized screen for inhibitors of Jumonji histonedemethylases 2009 ·Molecular BioSystems ·Masaaki Sakurai, Nathan R. Rose, Lena Schultz, Amy Quinn, Ajit Jadhav, Stanley S. Ng, Udo Oppermann, Christopher J. Schofield, Anton Simeonov	76
14	Tic32, an essential component in chloroplast biogenesis. (vol 279, pg 34756, 2004) 2009 ·Journal of Biological Chemistry ·(unknown), (unknown), Dmitry Sveshnikov, Udo Oppermann, Yucheng Li, (unknown)	5
15	Structural Basis for Substrate Specificity in Human Monomeric Carbonyl Reductases 2009 ·PLoS ONE ·Ewa S. Pilka, F. Niesen, Wen‐Hwa Lee, (unknown), James E. Dunford, Grazyna Kochan, Vladimı́r Wsól, (unknown), Edmund Maser, Udo Oppermann	50
16	Evaluation of Micro-Parallel Liquid Chromatography as a Method for HTS-Coupled Actives Verification 2007 ·Assay and Drug Development Technologies ·Anton Simeonov, Adam Yasgar, (unknown), Wei Zheng, N. Shafqat, Udo Oppermann, Christopher P. Austin, James Inglese	4
17	Kinetic analysis of conformational changes in farnesyl pyrophosphate synthase induced by nitrogen containing bisphosphonates 2007 ·Calcified Tissue International ·James E. Dunford, K.L. Kavanagh, Michael J. Rogers, Udo Oppermann, (unknown), R.G.G. Russell	3
18	Human type 10 17β-hydroxysteroid dehydrogenase: molecular modelling and substrate docking 2001 ·Journal of Molecular Graphics and Modelling ·Erik Nordling, Udo Oppermann, Hans Jörnvall, Bengt Persson	12
19	Metabolic conversion as a pre‐receptor control mechanism for lipophilic hormones 2001 ·European Journal of Biochemistry ·Stefan Nobel, Lars Abrahmsén, Udo Oppermann	72
20	Cloning and Primary Structure of Murine 11β‐Hydroxysteroid Dehydrogenase/Microsomal Carbonyl Reductase 1995 ·European Journal of Biochemistry ·Udo Oppermann, K.J. Netter, Edmund Maser	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact